Lakefront Biotherapeutics NV
Pharmaceutical company · 2800 Mechelen, Flanders, Belgium · Nasdaq: LKFT
Lakefront Biotherapeutics NV is a pharmaceutical company headquartered in 2800 Mechelen, Flanders, Belgium. Its shares trade on Nasdaq under the ticker LKFT.
Profile compiled from public records. Is this your company? Request a correction or update
Lakefront Biotherapeutics at a glance
Typepharmaceutical company
Headquarters2800 Mechelen, Flanders, Belgium
Stock listingNasdaq: LKFT
SEC industryPharmaceutical Preparations
SEC CIK1421876
Frequently asked questions about Lakefront Biotherapeutics
Where is Lakefront Biotherapeutics headquartered?
Lakefront Biotherapeutics NV is headquartered in 2800 Mechelen, Flanders, Belgium.
What does Lakefront Biotherapeutics do?
Lakefront Biotherapeutics NV is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Lakefront Biotherapeutics a public company?
Yes. Lakefront Biotherapeutics NV trades on Nasdaq under the ticker LKFT.
Similar companies
- TiGenix NVLeuven, Flanders, Belgium
- Celyad Oncology SAMont-Saint-Guibert, Wallonia, Belgium
- argenx BVGent, Flanders, Belgium
- HenogenSeneffe, Wallonia, Belgium
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences